This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Value Line's Q4 Earnings Fall Y/Y on Print Revenue Decline
by Zacks Equity Research
Value Line's Q4 earnings fall year over year to 42 cents per share, pressured by declining print subscriptions and higher operating costs, though strong EAM distributions provided some respite.
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and Sypris
by Zacks Equity Research
Bank of America, Chevron, Stryker, Value Line and Sypris are included in this Analyst Blog.
Top Analyst Reports for Bank of America, Chevron & Stryker
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), Chevron Corporation (CVX) and Stryker Corporation (SYK), as well as two micro-cap stocks Value Line, Inc. (VALU) and Sypris Solutions, Inc. (SYPR).
Value Line Q3 Earnings Decline Y/Y on Elevated Costs, Stock Down 8%
by Zacks Equity Research
VALU's fiscal Q3 earnings per share decline year over year as rising costs pressure margins, while higher income from EAM helps offset weaker publishing and copyright revenue.
The Zacks Analyst Blog Highlights Home Depot, Booking Holdings, Eaton and Value Line
by Zacks Equity Research
Home Depot, Booking Holdings, Eaton and Value Line are included in this Analyst Blog.
Top Analyst Reports for Home Depot, Booking & Eaton
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Booking Holdings Inc. (BKNG) and Eaton Corporation plc (ETN), as well as a micro-cap stock Value Line, Inc. (VALU).
Value Line Stock Rises 1% Since Q2 Earnings Surging Y/Y
by Zacks Equity Research
VALU's fiscal second-quarter earnings jump 62% year over year, driven by strong EAM revenues and investment gains. Shareholder equity shows strong improvement.
The Zacks Analyst Blog Highlights Alibaba, Linde, Abbott Laboratories and Value Line
by Zacks Equity Research
Alibaba, Linde, Abbott Laboratories and Value Line are part of the Zacks top Analyst Blog.
Top Analyst Reports for Alibaba, Linde & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Linde plc (LIN) and Abbott Laboratories (ABT), as well as a micro-cap stock Value Line, Inc. (VALU).
Value Line's Q1 Earnings Increase Y/Y on EAM Growth
by Zacks Equity Research
VALU posted a 21% increase in Q1 net income, fueled by a 48% surge in EAM-related revenue and strong investment gains. Shareholders' equity also rose 3.4% during the quarter.
Value Line (VALU) Q4 Earnings Up Y/Y, EAM Interest Drives Growth
by Zacks Equity Research
Value Line (VALU) reports an 18.6% year-over-year increase in net income during the quarter ended Apr 30, 2024. It has also declared increased dividends for the tenth consecutive year.
Zacks Initiates Coverage of Value Line With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks rates Value Line as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore its diversified revenue, strong balance sheet, and appealing dividend profile while examining challenges like declining core product revenues and dependency on EAM Trust.